Photocure Stock Current Asset
| PHO Stock | NOK 56.40 1.00 1.74% |
Photocure fundamentals help investors to digest information that contributes to Photocure's financial success or failures. It also enables traders to predict the movement of Photocure Stock. The fundamental analysis module provides a way to measure Photocure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Photocure stock.
Photocure |
Photocure Company Current Asset Analysis
Photocure's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Photocure Current Asset | 195 M |
Most of Photocure's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Photocure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Photocure has a Current Asset of 195 M. This is 90.94% lower than that of the Pharmaceuticals sector and 98.62% lower than that of the Health Care industry. The current asset for all Norway stocks is 97.91% higher than that of the company.
Photocure Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Photocure's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Photocure could also be used in its relative valuation, which is a method of valuing Photocure by comparing valuation metrics of similar companies.Photocure is currently under evaluation in current asset category among its peers.
Photocure Fundamentals
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 2.77 B | |||
| Shares Outstanding | 27.11 M | |||
| Shares Owned By Insiders | 2.98 % | |||
| Shares Owned By Institutions | 48.69 % | |||
| Price To Earning | 91.78 X | |||
| Price To Book | 6.33 X | |||
| Price To Sales | 7.76 X | |||
| Revenue | 360.54 M | |||
| Gross Profit | 336.49 M | |||
| EBITDA | 16.3 M | |||
| Net Income | (30.9 M) | |||
| Cash And Equivalents | 319.04 M | |||
| Cash Per Share | 4.20 X | |||
| Total Debt | 12.5 M | |||
| Debt To Equity | 5.50 % | |||
| Current Ratio | 3.04 X | |||
| Book Value Per Share | 17.69 X | |||
| Cash Flow From Operations | 23.89 M | |||
| Earnings Per Share | (2.53) X | |||
| Target Price | 141.67 | |||
| Number Of Employees | 97 | |||
| Beta | 0.79 | |||
| Market Capitalization | 3.07 B | |||
| Total Asset | 789.65 M | |||
| Retained Earnings | 153 M | |||
| Working Capital | 163 M | |||
| Current Asset | 195 M | |||
| Current Liabilities | 32 M | |||
| Net Asset | 789.65 M |
About Photocure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Photocure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Photocure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Photocure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Photocure Stock
Photocure financial ratios help investors to determine whether Photocure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure security.